This site is intended for healthcare professionals

FDA Advisory Committee votes in support of ALKS 3831 for the treatment of schizophrenia and bipolar I disorder.- Alkermes

Read time: 1 mins
Last updated:10th Oct 2020
Published:11th Oct 2020
Condition: Schizophrenia + Bipolar Disorder
Type: drug
Register free for full access to